How Trx80-Activated Monocytes Fight Bacterial Infections
Author Information
Author(s): Cortes-Bratti Ximena, Bassères Eugénie, Herrera-Rodriguez Fabiola, Botero-Kleiven Silvia, Coppotelli Giuseppe, Andersen Jens B., Masucci Maria G., Holmgren Arne, Chaves-Olarte Esteban, Frisan Teresa, Avila-Cariño Javier
Primary Institution: Karolinska Institutet, Stockholm, Sweden
Hypothesis
Trx80-activated monocytes (TAMs) enhance the immune response against intracellular bacterial infections.
Conclusion
Trx80-activated monocytes effectively control the replication of intracellular bacteria like Listeria monocytogenes and Brucella abortus.
Supporting Evidence
- TAMs inhibit the growth of Listeria monocytogenes and Brucella abortus.
- Trx80 activation leads to higher expression of CD14 on monocytes.
- TAMs show enhanced bactericidal activity by preventing bacterial escape from phagosomes.
Takeaway
This study shows that a special type of immune cell, called TAMs, can help our body fight off certain bacteria by keeping them trapped and preventing them from growing.
Methodology
The study involved isolating human monocytes, activating them with Trx80, and then infecting them with Listeria monocytogenes and Brucella abortus to assess bacterial replication.
Participant Demographics
Human peripheral blood mononuclear cells were used, sourced from healthy donors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website